IMIDAZO[1,2-A]PYRAZINE MODULATORS OF THE ADENOSINE A2A RECEPTOR

The present invention relates to the compound of formula (I) and salts, stereoisomers, tautomers, isotopologues,or N-oxides thereof. The present invention is further concerned with the use of such a compound or salt, stereoisomer, tautomer, isotopologues,or N-oxide thereof as medicament and a pharma...

Full description

Saved in:
Bibliographic Details
Main Authors ZACHMANN, Julian, BOBOWSKA (NÉE WITKOWSKA), Aneta, DZIELAK, Anna, NOWAK, Mateusz, FOGT, Joanna, FABRITIUS, Charles-Henry, ZASTAWNA, Magdalena, SZEREMETA-SPISAK, Joanna, GALEZOWSKI, Michal, COMMANDEUR, Claude, NOWOGRODZKI, Marcin, WRONOWSKI, Marek, LOZINSKA, Iwona, PORTER, Rod, RADZIMIERSKI, Adam, SWIRSKI, Mateusz, JANIGA, Anita, DUDEK (NÉE SEDLAK), Marcelina, REUS, Jacek, OBARA, Alicja
Format Patent
LanguageEnglish
French
Published 03.01.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the compound of formula (I) and salts, stereoisomers, tautomers, isotopologues,or N-oxides thereof. The present invention is further concerned with the use of such a compound or salt, stereoisomer, tautomer, isotopologues,or N-oxide thereof as medicament and a pharmaceutical composition comprising said compound. La présente invention concerne un composé de formule (I) et des sels, des stéréoisomères, des tautomères, des isotopologues, ou des N-oxydes de celui-ci. La présente invention concerne en outre l'utilisation d'un tel composé ou sel, stéréoisomère, tautomère, isotopologues, ou N-oxyde de celui-ci en tant que médicament et une composition pharmaceutique contenant ledit composé.
Bibliography:Application Number: WO2018EP67701